Wang A, Ma W G, Wang C D, Zhang H Q, Liu F
Department of Burns and Plastic Surgery, Yidu Central Hospital of Weifang, Weifang 262500, China.
Department of Interventional Therapy, Yidu Central Hospital of Weifang, Weifang 262500, China.
Zhonghua Shao Shang Za Zhi. 2021 Jan 20;37(1):42-48. doi: 10.3760/cma.j.cn501120-20200105-00004.
To investigate the clinical effects of autologous platelet rich plasma (PRP) gel in combination with vacuum sealing drainage (VSD) technology in repairing refractory wounds. From March 2011 to January 2015, 44 patients with refractory wounds meeting the inclusion criteria were recruited into VSD alone group, who were admitted to the Department of Burns and Plastic Surgery of the Yidu Central Hospital of Weifang and received intermittent VSD treatment. From February 2015 to September 2019, 43 patients with refractory wounds meeting the inclusion criteria were recruited into PRP+ VSD group, who were admitted to the same unit as above-mentioned and received PRP combined with intermittent VSD treatment. The retrospective cohort study was conducted. There were 24 males and 20 females with age of (37.5±2.2) years in VSD alone group, and there were 25 males and 18 females with age of (37.0±2.5) years in PRP+ VSD group. The wound exudate of patients in the two groups before and 7 and 14 d after the first treatment were collected for bacterial culture, and the positive rate of bacterial culture was calculated. The wound healing of patients in the two groups was observed on 7, 14, and 21 d after the first treatment, and the wound healing rate was calculated. The complete wound healing time of patients in the two groups was recorded. The degree of wound pain of patients in the two groups was evaluated by the Visual Analog Scale (VAS) before and 14 d after the first treatment. The scar hyperplasia of patients in the two groups was evaluated by the Vancouver Scar Scale (VSS) in 1 and 2 months after the wound healed completely. The occurrence of adverse reactions of patients in the two groups during the whole period of treatment was observed and the incidence of adverse reactions was calculated. Data were statistically analyzed with analysis of variance for repeated measurement, chi-square test, paired test, and Bonferroni correction. The positive rates of bacterial culture in wound exudate of patients in PRP+ VSD on 7 and 14 d after the first treatment were 37.2% (16/43) and 11.6% (5/43), which were significantly lower than 56.8% (25/44) and 29.5% (13/44) in VSD alone group, (2)=4.212, 4.255, <0.05. The wound healing rates of patients in PRP+ VSD group on 7 and 14, and 21 d after the first treatment were respectively (58±14)%, (70±13)%, (89±12)%, which were significantly higher than (41±11)%, (60±11)%, (74±12)% in VSD alone group, =6.323, 3.820, 5.751, <0.01. The complete wound healing time of patients in PRP+ VSD group was (30±6) d, which was significantly shorter than (61±8) d in VSD alone group, =20.890, <0.05. The VAS score of patients in PRP+ VSD group was significantly lower than that in VSD alone group on 14 d after the first treatment (=13.904, <0.01). The VSS score of patients in PRP+ VSD group was significantly lower than that in VSD alone group in 1 and 2 months after the wound healed completely (=3.307, 3.637, <0.01). The incidence of adverse reactions of patients in PRP+ VSD group during the whole period of treatment was 7.0% (3/43), which was significantly lower than 22.7% (10/44) in VSD alone group, (2)=4.245, <0.05. Autologous PRP gel combined with VSD technology in repairing refractory wounds not only has good bacteriostatic effect, but also can increase wound healing rate, shorten wound healing time, alleviate wound pain, reduce scar hyperplasia, with less adverse reaction, which is worthy of promotion.
探讨自体富血小板血浆(PRP)凝胶联合封闭负压引流(VSD)技术修复难治性创面的临床效果。选取2011年3月至2015年1月符合纳入标准的44例难治性创面患者纳入单纯VSD组,均收治于潍坊市益都中心医院烧伤整形科,接受间歇性VSD治疗。选取2015年2月至2019年9月符合纳入标准的43例难治性创面患者纳入PRP+VSD组,均收治于上述同一科室,接受PRP联合间歇性VSD治疗。进行回顾性队列研究。单纯VSD组男24例,女20例,年龄(37.5±2.2)岁;PRP+VSD组男25例,女18例,年龄(37.0±2.5)岁。收集两组患者首次治疗前及首次治疗后7、14 d创面渗液进行细菌培养,计算细菌培养阳性率。观察两组患者首次治疗后7、14、21 d创面愈合情况,计算创面愈合率。记录两组患者创面完全愈合时间。采用视觉模拟评分法(VAS)评估两组患者首次治疗前及首次治疗后14 d创面疼痛程度。采用温哥华瘢痕量表(VSS)评估两组患者创面完全愈合后1、2个月瘢痕增生情况。观察两组患者整个治疗期间不良反应发生情况并计算不良反应发生率。采用重复测量方差分析、卡方检验、配对t检验及Bonferroni校正进行统计学分析。PRP+VSD组患者首次治疗后7、14 d创面渗液细菌培养阳性率分别为37.2%(16/43)、11.6%(5/43),明显低于单纯VSD组的56.8%(25/44)、29.5%(13/44),χ²=4.212、4.255,P<0.05。PRP+VSD组患者首次治疗后7、14、21 d创面愈合率分别为(58±14)%、(70±13)%、(89±12)%,明显高于单纯VSD组的(41±11)%、(60±11)%、(74±12)%,F=6.323、3.820、5.751,P<0.01。PRP+VSD组患者创面完全愈合时间为(30±6)d,明显短于单纯VSD组的(61±8)d,t=20.890,P<0.05。PRP+VSD组患者首次治疗后14 d VAS评分明显低于单纯VSD组(t=13.904,P<0.01)。PRP+VSD组患者创面完全愈合后1、2个月VSS评分明显低于单纯VSD组(t=3.307、3.637,P<0.01)。PRP+VSD组患者整个治疗期间不良反应发生率为7.0%(3/43),明显低于单纯VSD组的22.7%(10/44),χ²=4.